ESR1 and neoplasm: For instance, tumor antigen presentation by dendritic cells (DCs) is enhanced in females through E2 and estrogen receptor alpha (ERα) signaling, which upregulates MHC class II expression and leads to more robust anti-tumor T cell responses.